MC

467.05

-1.1%↓

SANES

10.262

+0.55%↑

SAF

272.1

+0.67%↑

BBVA

18.665

+0.76%↑

BNP

89.84

+0.99%↑

MC

467.05

-1.1%↓

SANES

10.262

+0.55%↑

SAF

272.1

+0.67%↑

BBVA

18.665

+0.76%↑

BNP

89.84

+0.99%↑

MC

467.05

-1.1%↓

SANES

10.262

+0.55%↑

SAF

272.1

+0.67%↑

BBVA

18.665

+0.76%↑

BNP

89.84

+0.99%↑

MC

467.05

-1.1%↓

SANES

10.262

+0.55%↑

SAF

272.1

+0.67%↑

BBVA

18.665

+0.76%↑

BNP

89.84

+0.99%↑

MC

467.05

-1.1%↓

SANES

10.262

+0.55%↑

SAF

272.1

+0.67%↑

BBVA

18.665

+0.76%↑

BNP

89.84

+0.99%↑

Search

Equasens

Chiusa

39.85 0.76

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

38

Massimo

40.45

Metriche Chiave

By Trading Economics

Entrata

4.8M

22M

Vendite

4.5M

121M

P/E

Media del settore

15.293

Rendimento da dividendi

3

Margine di Profitto

18.286

Dipendenti

1,400

EBITDA

-183M

-67M

Dividendi

By Dow Jones

Rendimento da dividendi

Media del settore

3.00%

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

56M

628M

Apertura precedente

39.09

Chiusura precedente

39.85

Equasens Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

26 apr 2026, 21:14 UTC

Principali Notizie su Eventi

Week Ahead for FX, Bonds: Major Central Bank Meetings Due as Middle East Conflict Continues

26 apr 2026, 21:14 UTC

Principali Notizie su Eventi

Week Ahead for FX, Bonds: Major Central Bank -2-

24 apr 2026, 19:19 UTC

Acquisizioni, Fusioni, Takeovers

Intertek Group Rejects EQT's Revised Offer

26 apr 2026, 23:48 UTC

Discorsi di Mercato

Nikkei May Rise After U.S. Tech Gains -- Market Talk

26 apr 2026, 23:44 UTC

Utili

Sinopharm 1Q Net CNY1.41B Vs. Net CNY1.46B >1099.HK

26 apr 2026, 23:44 UTC

Utili

Sinopharm 1Q Rev CNY140.77B Vs. CNY141.66B >1099.HK

26 apr 2026, 23:36 UTC

Discorsi di Mercato
Principali Notizie su Eventi

Gold Falls Amid Dollar's Strength -- Market Talk

26 apr 2026, 23:33 UTC

Discorsi di Mercato
Principali Notizie su Eventi

Oil Rises Amid Ongoing Middle East Tensions -- Market Talk

26 apr 2026, 05:12 UTC

Utili

Citic Securities: Results Also Aided by Higher Income from Brokerage, Income Banking Business >6030.HK

26 apr 2026, 05:12 UTC

Utili

Citic Securities: Increase in Net Interest Income Supported Results >6030.HK

26 apr 2026, 05:12 UTC

Utili

Citic Securities 1Q Rev CNY23.16B Vs. CNY16.43B >6030.HK

26 apr 2026, 05:12 UTC

Utili

Citic Securities 1Q Net CNY10.22B Vs. Net CNY6.61B >6030.HK

24 apr 2026, 23:37 UTC

Acquisizioni, Fusioni, Takeovers

Scoring the Cook Era -- Barrons.com

24 apr 2026, 20:51 UTC

Acquisizioni, Fusioni, Takeovers

Organon Stock Surges 31% on Sweetened $13 Billion Takeover Offer From Sun Pharma -- Barrons.com

24 apr 2026, 20:50 UTC

Discorsi di Mercato
Principali Notizie su Eventi

Financial Services Roundup: Market Talk

24 apr 2026, 20:50 UTC

Discorsi di Mercato

Basic Materials Roundup: Market Talk

24 apr 2026, 20:39 UTC

Acquisizioni, Fusioni, Takeovers

Organon Stock Surges 31% on Sweetened $13 Billion Takeover Offer From Sun Pharma -- Barrons.com

24 apr 2026, 20:09 UTC

Utili

Tesla Stock Rises After Upgrade But Heads for Weekly Loss. Why AI Is Key. -- Barrons.com

24 apr 2026, 19:48 UTC

Discorsi di Mercato
Principali Notizie su Eventi

Oil Posts Weekly Gains on Continued Hormuz Closure -- Market Talk

24 apr 2026, 19:25 UTC

Acquisizioni, Fusioni, Takeovers

Organon Stock Surges 30% on Sweetened $13 Billion Takeover Offer From Sun Pharma -- Barrons.com

24 apr 2026, 19:25 UTC

Acquisizioni, Fusioni, Takeovers

QXO Continues to Tumble Following TopBuild Deal -- Barrons.com

24 apr 2026, 19:22 UTC

Utili

Dell AI Infrastructure Deal Shows That Hyperscalers Aren't the Only Players. Plus, Adobe and 4 More Stocks. -- Barrons.com

24 apr 2026, 19:06 UTC

Utili

Earnings Season Was Supposed to Drive the Stock Market. Why It Hasn't. -- Barrons.com

24 apr 2026, 19:05 UTC

Discorsi di Mercato

U.S. Natural Gas Falls As Market Frets Over Storage -- Market Talk

24 apr 2026, 18:30 UTC

Acquisizioni, Fusioni, Takeovers

Intertek: EQT's GBP54/Shr Offer 'Fundamentally Undervalues Intertek and Its Future Prospects'

24 apr 2026, 18:28 UTC

Acquisizioni, Fusioni, Takeovers

Intertek Rejects Revised EQT Offer

24 apr 2026, 18:12 UTC

Discorsi di Mercato

Precious Metals Rise, But Remain Negative for the Week -- Market Talk

24 apr 2026, 18:06 UTC

Discorsi di Mercato

Oil Futures Extend Losses on Plans for U.S.-Iran Talks -- Market Talk

24 apr 2026, 17:42 UTC

Utili

Even Nvidia Stock Is Getting an Intel Boost. It's on Pace for a Record High. -- Barrons.com

24 apr 2026, 17:28 UTC

Utili

Palantir Stock Is Down 20% in 2026. Why This Analyst Says It's a Buy. -- Barrons.com

Confronto tra pari

Modifica del prezzo

Equasens Previsione

Consenso sulla valutazione

By TipRanks

0 ratings

0

Acquista

0

Mantieni

0

Vendi

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo Equasens

Equasens Société anonyme provides healthcare IT solutions in Europe. The company develops electronic equipment, digital and robotic health, and equipment lease financing solutions. It also offers id., a pharmacy management software suite; id. PATIENT for the exchange of healthcare data; id. VENTE, which facilitates and secures prescription sales; id. COMMANDE, which manages orders and inventory; dispensing robots; Ségur id. services; FARMACLICK, a communication protocol; DIFARM, a modular solution for wholesalers-distributors; and PHARE, a retail management tool. In addition, the company offers patient medication adherence, patient loyalty, point-of-sale commercial performance, piloting pharmacy operations, pharmacy team training, securing pharmacy operations and health data, and digital communication solutions; and in-home nursing services and hospital-at-home, hospitals, and telemedicine solutions. Further, it provides id. DESK, an informative and interactive dashboard; id. UP!, a smartphone app; id. EASYQ, a queuing management solution; Miaterapia, a patient app; and MediStory for tracking patient records; ExpressVitale module; and MEDILINK, a health data hosting provider. Additionally, the company offers KAP&LINK2, a terminal with smart card and NFC reader; eS-KAP-Ad, a mobile device with a pre-loaded software; KAP-INSIDE, a mobile terminal; TI-KAP, which allows access to contact and contactless cards; AUTHENTIFICATEUR, a patented patient authentication system; KAP'TEUR by KAPELSE, a patented universal sensor; and NOVIAcare, which analyzes the behavior and activity of the elderly. It serves nursing homes, hospitals, in-house nursing care and hospital-at-home programs, regional health professional communities, multidisciplinary group practices, and individual healthcare professionals. The company was incorporated in 1996 and is headquartered in Villers-les-Nancy, France. Equasens Société anonyme is a subsidiary of Marque Verte Sante.
help-icon Live chat